Johnson & Johnson Announces Collaboration With Sail Biomedicines to Advance in Vivo CAR-T Programs and Transform Autoimmune Disease Through Immune Reset
July 30, 2026
July 30, 2026
RARITAN, New Jersey, July 30 -- Johnson and Johnson Innovative Medicine issued the following news release on July 29, 2026:
* * *
Johnson & Johnson Announces Collaboration with Sail Biomedicines to Advance in vivo CAR-T Programs and Transform Autoimmune Disease Through Immune Reset
Key takeaways
Advances differentiated immunology program with the potential to address significant unmet need in immune-mediated disease
Novel in vi . . .
* * *
Johnson & Johnson Announces Collaboration with Sail Biomedicines to Advance in vivo CAR-T Programs and Transform Autoimmune Disease Through Immune Reset
Key takeaways
Advances differentiated immunology program with the potential to address significant unmet need in immune-mediated disease
Novel in vi . . .